MAPT and Alzheimer disease: BIN1 can mitigate tau pathology in specific brain regions of transgenic mouse models of AD, including the entorhinal/piriform cortex, hippocampus, and amygdala, thereby inhibiting neuronal cell death, synaptic loss, and neuroinflammation [64].